Efficacy and Safety of Dexketoprofen extended release tablet in the Treatment of Osteoarthritis
- Registration Number
- CTRI/2009/091/000932
- Lead Sponsor
- Emcure Pharmaceuticals Ltd, Pune
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 0
? Male or female patients between 40-75 years of age.
? Willing to give written informed consent and willing to comply with trial protocol.
? Clinically and/or radiologically diagnosed to have OA or are known OA patients
? Patient and / or physician?s global assessment of arthritic condition as fair, poor or very poor.
? Patients with normal laboratory values.
? Patients not on any anti-inflammatory or other therapy known to affect the study outcome.
? Patients with history of any drug allergy or intolerance to NSAIDs.
? Severe hypertension or uncontrolled hypertension
? Patients with H/O or evidence of renal, hepatic or neurologic diseases
? Uncontrolled diabetes
? Women who are pregnant, lactating, of child bearing potential who are not practicing effective methods of contraception.
? Any condition that, in the opinion of the investigator, does not justify the patient?s inclusion in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method